Bangladesh Has 424 Measles Deaths and a Government That Won't Name the Decision
The Bangladesh measles toll reached 424 on Wednesday — and the Rahman government insists there was no procurement change, while the paper trail says otherwise.
Life
A Pancreatic Cancer Drug Moved the Survival Line by Six Months
Revolution Medicines' daraxonrasib nearly doubled median survival in pancreatic cancer versus chemotherapy — the largest gain in a decade, and oncologists are calling it a landmark.
The United States Is Now Losing More People Than It Gains
For the first time in 50 years, more people left the US than arrived in 2025 — a demographic reversal whose consequences run from Social Security tables to empty school seats.
Lake Powell's Worst Inflow Year on Record Has No Easy Answer
A federal hydrologist said 'no good news' at a May 8 NOAA webinar — 2026's Lake Powell inflow is 13% of normal, the worst in the reservoir's 60-year history.
Microplastics Are Now a Climate Problem — Not Just an Ocean Problem
A Nature Climate Change study finds airborne microplastics account for 16.2% of black carbon forcing — potentially changing how governments count what is warming the planet.
El Nino Odds Hit 61 Percent With a Super El Nino Now at 50-50
NOAA puts El Nino development at 61 percent through July — and a Super El Nino above 2 degrees Celsius is now a coin flip.
Right Whale Calving Season Closed at 23 — That Is the Best Since 2009
The North Atlantic right whale calving season has officially closed at 23 confirmed calves — a 17-year high that is now a final count, not a projection.
A GLP-1 Drug That Activates Only Inside Cells May Work Better Than Ozempic
A Nature preclinical study describes an intracellular GLP-1 agonist that outperforms the standard GLP-1/GIP combination — in mice, not humans.
McGill Found One Enzyme That Governs Both Fat-Burning and Bone-Building
McGill researchers publishing in Nature identified glycerol as the molecule that activates TNAP, linking brown fat thermogenesis directly to bone mineralization.
UNICEF's Objection to Bangladesh's Vaccine Procurement Switch Said For God's Sake, Don't Do This
UNICEF documented its objection to Bangladesh's September 2025 procurement change with the phrase 'for God's sake'; the Rahman government reversed the change in April.
PAHO's US Measles Elimination Review Is Six Months Away — the Count Is 1,842
The US has 1,842 measles cases in 2026 — the highest since 1992 — and PAHO reviews US elimination status in November.
Lake Powell Is at 23 Percent Capacity on 13 Percent of Normal Inflow — No Good News
A federal hydrologist said 'no good news' at NOAA's May 8 webinar — Lake Powell sits at 23 percent capacity on 13 percent of normal spring inflow.
FDA Cleared Expanded Access to Daraxonrasib After Phase 3 Results Showed 13 Months Versus 6.7
FDA cleared expanded access for daraxonrasib after Phase 3 data showed 13.2 versus 6.7 months median overall survival in first-line pancreatic cancer.
Coffee Reshapes the Gut Microbiome Whether or Not It Has Caffeine
A Nature Communications trial from UC Cork shows coffee's microbiome effect is independent of caffeine — decaf improves memory, caffeinated coffee sharpens focus.
Spartanburg Ended With 997 Measles Cases — and the Question of the Next County
South Carolina's outbreak closed at 997 cases — the nation's largest in 35 years — and Utah's now-rising count is the obvious next chapter.
Daraxonrasib Cut Pancreatic Cancer's Median Survival Gap by More Than Half
Phase 3 data: 13.2 months median overall survival vs 6.7 months on control — NEJM-published, FDA expanded access cleared.